Skip to content

Food Insecurity in Oncology

Food Insecurity in Oncology (FIOnc)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05176743
Acronym
FIOnc
Enrollment
44
Registered
2022-01-04
Start date
2021-08-30
Completion date
2022-06-20
Last updated
2022-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Food Insecurity

Brief summary

This trial will examine the feasibility and preliminary effectiveness of providing unconditional cash transfers to food insecure female breast and gynecologic cancer patients. Approximately one-third of cancer survivors report food insecurity, characterized by limited access to adequate food for active, healthy living because of a lack of money and other resources. Unconditional cash transfers offer direct monetary assistance that can be used to meet immediate food or other financial needs and may positively impact health care resource utilization and health-related quality of life.

Detailed description

In this delayed intervention trial, 44 female breast and gynecologic cancer patients experiencing food insecurity will be randomized in a 1:1 ratio to receive unconditional cash transfers (UCT) for 3 months or an equivalent one-time UCT at the end of the study. Quantitative surveys will be administered at baseline and after 3-months. Survey measures will include questions about health care resource utilization, health-related quality of life, food security, hospitalization use, emergency department use, and mental health. The main objective for this pilot trial is to assess feasibility. The investigators will measure whether the investigators can: recruit 44 food insecure participants meeting the eligibility criteria over a 3-month recruitment window and describe the barriers and facilitators of the recruitment process. The investigators will also monitor retention and survey completion. At the end of the 3 month follow-up period, all participants will complete a semi-structured exit interview.

Interventions

The UCT consists of three $100 VISA merchandise cards provided monthly via mail to participants randomized to the intervention arm. Merchandise cards can be used anywhere that VISA is accepted. Participants in the UCT arm will also receive Usual Care, including referral to the patient support services team and nutritional pamphlets.

Sponsors

University of New Mexico Cancer Center
CollaboratorOTHER
Wake Forest University Health Sciences
CollaboratorOTHER
National Cancer Institute (NCI)
CollaboratorNIH
New Mexico Cancer Research Alliance
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Masking description

No blinding will be used in this pilot trial.

Intervention model description

This is a randomized pilot trial. Eligible individuals will be identified from breast and gynecologic clinics in the New Mexico Cancer Care Alliance. Participants will be screened for food insecurity and asked to complete a baseline survey. Participants will then be randomized to either Usual Care or to the UCT intervention. All participants will complete a 3-month follow-up, survey and a qualitative exit interview.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of female breast (ICD-10 C50), ovarian (ICD-10 C56), endometrial (ICD-10 C54), cervical (ICD-10 C53), vulvar cancer (ICD-10 C51) * Diagnosed within 24-months of identification * Stage I-III * Completed initial course of cancer directed therapy (surgery, radiation, chemotherapy). * Age ≥18 * Able to speak English or Spanish * Food insecure

Exclusion criteria

* Adults unable to consent * Individuals who are not yet adults (infants, children, teenagers) * Prisoners

Design outcomes

Primary

MeasureTime frame
Determine the percentage of referred patients who are eligible to enroll in the study and choose to do so3 months
Determine the percentage of patients who complete both the baseline and 3 month follow-up survey3 months
Determine the number of participants who complete the surveys3 months

Secondary

MeasureTime frameDescription
Assess the number of participants who are food insecure using the Hunger VitalSign food insecurity screening tool3 months
Determine the number of patients who use the Emergency Department during the 3 month follow-up period as well as how many visits they have3 months
Determine the number of patients who report being hospitalized during the 3 month follow-up period as well as the number of times they are hospitalized3 months
Assess healthcare resource utilization using the PhenX-Access to Health Services toolkit3 months
Assess participants perceived self-efficacy using the PROMIS Self-Efficacy for Managing Medications and Treatments 4a questionnaire3 monthsThe 4 questions that comprise this measure are measured on a Likert scale with 1 representing that the respondent is not at all confident completing the described task and 5 representing that the respondent is very confident completing the task. Raw scores range from 4-20, but T-score conversions are needed for interpretation. A higher PROMIS T-score indicates a person whose health is better than the average respondent.
Assess incidence of participant stress using the Perceived Stress Scale (PSS-10)3 months
Assess number of participants experiencing depression using the Patient Health Questionnaire (PHQ-9) screener tool3 months
Healthcare costs3 months
Assess health-related quality of life using the PROMIS Global Health 10 item questionnaire3 monthsNine of the Global Health PROMIS measures items are scored on a Likert scale, with 1 representing the worst health situation and 5 representing the best health situation. Pain is scored from 0 to 10 with 0 indicating no pain and 10 representing the worst pain ever experienced. Two sub-scores can also be derived from the 10 item questionnaire to assess physical and mental health separately. Raw scores must be converted to a standardized T-score for interpretation. A higher PROMIS T-score indicates a person whose health is better than the average respondent.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026